These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12043071)

  • 1. [Opportunistic diseases again on the increase? Study shows tendency for change in the trend].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2002 Apr; 144 Suppl 1():33-9. PubMed ID: 12043071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis and treatment of opportunistic infection in patients on HAART.
    Tantisiriwat W; Powderly WG
    AIDS Read; 1999; 9(2):122-30. PubMed ID: 12728894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of highly active antiretroviral therapy on incidence and management of human immunodeficiency virus-related opportunistic infections.
    Hung CC; Chang SC
    J Antimicrob Chemother; 2004 Nov; 54(5):849-53. PubMed ID: 15456733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
    Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opportunistic diseases. Risk can be estimated].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2003 Apr; 145 Spec No 1():33-7. PubMed ID: 15011582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Opportunistic infections. Developments and trends since establishment of HAART therapy].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():56-60. PubMed ID: 11373785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
    Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
    Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
    San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A
    Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
    Ortega KL; Vale DA; Magalhães MH
    J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Leprosy and immune reconstitution syndrome in AIDS].
    Aubry P; Bobin P
    Bull Soc Pathol Exot; 2008 Feb; 101(1):58-9. PubMed ID: 18432011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.
    Chaiwarith R; Charoenyos N; Sirisanthana T; Supparatpinyo K
    AIDS; 2007 Jan; 21(3):365-7. PubMed ID: 17255744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
    Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
    Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia.
    Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W
    Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
    Sacktor N
    J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of triple antiretroviral therapy on Tunisian AIDS profile: study of 139 cases].
    Zouiten F; Ammari L; Goubantini A; Tiouiri H; Slim A; Maamouri A; Kilani B; Kanoun F; Marrakchi C; Neifer N; Mihoub L; Jenhani F; Garbouj M; Ben Chaabane T
    Tunis Med; 2003 Dec; 81(12):956-62. PubMed ID: 14986532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective multicentre study of discontinuing prophylaxis for opportunistic infections after effective antiretroviral therapy.
    Green H; Hay P; Dunn DT; McCormack S;
    HIV Med; 2004 Jul; 5(4):278-83. PubMed ID: 15236617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.